A new study adds to evidence that rosiglitazone -- a drug used to treat type 2 diabetes -- is associated with an increased risk of heart problems, especially heart failure.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200205210830.htm
No comments:
Post a Comment